Demographic and clinical characteristics of the Patient cohort.

HCV viral genotype was not available for 357 individuals in the HCV mono-infection group and 74 individuals in the HCV-HBV co-infection group; however, those with undetermined genotype results were not among the treated patients.
▲P<0.05, HBV versus HCV group
*P<0.05, HCV versus HBV-HCV group
#P<0.05, HBV versus HBV-HCV group
Quantitative variables are displayed as interquartile range (range), except age.APRI and FIB-4 level which are displayed as mean±SD BMI, body mass index; ALT, alanine aminotransferase, Normal value: 8–50.00 U/L; AST, aspartate aminotransferase, Normal value: 8–40.00 U/L; ALP, alkaline phosphatase, Normal value: 15–112.00 U/L; GGT, glutamyl transpeptidase, Normal value: 5–54.00 U/L; TP, total protein, Normal value: 60–83.00 g/l; ALB, albumin, Normal value: 35–55.00 g/l; GLB, globulin, Normal value: 20–30.00 g/L; TBIL, total bilirubin, Normal value: 6.8–30.00 μmol/L; DBIL, direct bilirubin, Normal value: 0–8.60 μmol/L; IBIL, indirect bilirubin, Normal value: 5.1–21.40 umol/L; CHE, cholinesterase, Normal value: 4300–12000.00 U/L; BUN, blood urea nitrogen, Normal value: 3.2–7.00 mmol/L; Cr, creatinine, Normal value: 44–115.00 μmol/L; TG, triglycerides, Normal value: 0.28–1.80 mmol/L; TC, total cholesterol,Normal value: 2.6–6.00 mmol/L; GLU, glucose,Normal value: 3.9–6.10 mmol/L; PLT, platelet,Normal value: 100–300.00 10^9/L; APRI, aspartate aminotransferase to platelet ratio index; FIB-4, fibrosis index based on the four factors score
Demographic and clinical characteristics of the Patient cohort.